UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030534
Receipt number R000034859
Scientific Title The Effect of Trimebutine Maleate in Capsule Enteroscopy
Date of disclosure of the study information 2017/12/23
Last modified on 2019/12/29 13:35:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Effect of Trimebutine Maleate in Capsule Enteroscopy

Acronym

The Effect of Trimebutine Maleate in Capsule Enteroscopy

Scientific Title

The Effect of Trimebutine Maleate in Capsule Enteroscopy

Scientific Title:Acronym

The Effect of Trimebutine Maleate in Capsule Enteroscopy

Region

Japan


Condition

Condition

small bowel disease

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We investigate the effect of trimebutine maleate on gastrointestinal transit time and diagnostic yield of capsule endoscopy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Gastrointestinal transit time of capsule endoscopy.

Key secondary outcomes

diagnostic yield of capsule endoscopy.
Field of clearly view in the gastrointestinal tract.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Medicine Device,equipment

Interventions/Control_1

the trimebutine maleate group

Interventions/Control_2

the control group

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patients who underwent CE
patients who had Chronic gastritis or Irritable bowel syndrome

Key exclusion criteria

Severe liver dysfunction,
pregnancy,
Patients taking of trimebutine maleate at registration

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Ryu
Middle name
Last name Nishiyama

Organization

Hiratsuka kyosai hospital

Division name

Department of Gastroenterology

Zip code

2548502

Address

Oiwake9-11,Hiratsuka-shi,Kanagawa,Japan

TEL

0463-32-1950

Email

ryuwest@jcom.zaq.ne.jp


Public contact

Name of contact person

1st name Ryu
Middle name
Last name Nishiyama

Organization

Hiratsuka kyosai hospital

Division name

Department of Gastroenterology

Zip code

2548502

Address

Oiwake9-11,Hiratsuka-shi,Kanagawa,Japan

TEL

0463-32-1950

Homepage URL


Email

ryuwest@jcom.zaq.ne.jp


Sponsor or person

Institute

Hiratsuka kyosai hospital
Department of Gastroenterology

Institute

Department

Personal name



Funding Source

Organization

Hiratsuka kyosai hospital
Department of Gastroenterology

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hiratsuka kyosai hospital IRB

Address

Oiwake9-11,Hiratsuka-shi,Kanagawa,Japan

Tel

0463-32-1950

Email

ryuwest@jcom.zaq.ne.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国家公務員共済組合連合会 平塚共済病院(神奈川県)


Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 12 Month 01 Day

Date of IRB

2017 Year 12 Month 04 Day

Anticipated trial start date

2017 Year 12 Month 04 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 12 Month 23 Day

Last modified on

2019 Year 12 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034859


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name